U
MR

UBS’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

UBS’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$12.1M Buy
400,000
+237,300
+146% +$7.35M 0.01% 1304
2014
Q2 		$5.13M Buy
+162,700
New +$5.16M ﹤0.01% 1948
2014
Q1 		– Sell
-100
Closed -$4K – 11207
2013
Q4 		$4K Hold
100
– – ﹤0.01% 9787
2013
Q3 		$4K Buy
+100
New +$4.03K ﹤0.01% 9658

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

UBS's MR Position: Q3 2014 in Review

UBS increased its MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) stake by 261% in Q3 2014, buying an estimated $10.2M and bringing the position to 456,671 shares worth $13.8M. The position accounts for 0.01% of the portfolio, ranked #1198.

UBS first reported a position in MR in Q2 2013 and has held it in 6 quarters since. 129 funds tracked by Wall St. Rank hold MR as of Q3 2014.

  • UBS held 456,671 shares of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A worth $13.8M as of Q3 2014.
  • UBS bought 330,007 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q3 2014, an estimated $10.2M.
  • MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A made up 0.01% of UBS's portfolio in Q3 2014, its #1198 holding.
  • UBS first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and has held it in 6 quarters since.
  • 129 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.